NewLimit
Developing epigenetic reprogramming medicines to extend human healthspan.
Company facts
- Founded
- 2021
- Employees
- 50
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $45M · 2025
Open positions
Group Lead, Immunology
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist, mRNA Downstream Purification
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist, mRNA Analytical Development
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Senior/Research Associate, mRNA Engineering
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist- Delivery Sciences-targeted LNPs (tLNPs)
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat aging by reprogramming the epigenome, a new therapeutic mechanism to restore youthful…
Principal/Senior Scientist, Translational Biomarkers
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist, Metabolism
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Senior/Research Associate, Single Cell Technology
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Director / Senior Director, Clinical Operations
Lead and manage first-in-human clinical trials for biotech startup developing epigenetic reprogramming medicines to treat aging and metabolic diseases, coordinating CROs and global sites.
Senior Scientist / Scientist, In Vivo Pharmacology
Company info NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…
Scientist/Senior Scientist, Immunology
Design and run immunology experiments to identify epigenetic therapies for inflammatory and autoimmune diseases, focusing on T cell and regulatory T cell biology.
Scientist/Senior Scientist
About NewLimit NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to…